174 related articles for article (PubMed ID: 30188568)
21. Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.
Bardazzi F; Barisani A; Magnano M; Tengattini V; La Placa M; Patrizi A; Balestri R
Eur J Dermatol; 2016 Aug; 26(4):390-1. PubMed ID: 27210833
[No Abstract] [Full Text] [Related]
22. Bullous pemphigoid with linear lesions and antibodies exclusively against the soluble ectodomain of BP180 (LAD-1).
Mahmoudi H; Toosi R; Kamyab K; Zillikens D; Schmidt E; Daneshpazhooh M
J Dtsch Dermatol Ges; 2019 Sep; 17(9):933-935. PubMed ID: 31353797
[No Abstract] [Full Text] [Related]
23. A possible association between BP230-type bullous pemphigoid and dementia: a report of two cases in elderly patients.
Zheng M; Ujiie H; Muramatsu K; Sato-Matsumura KC; Maeda T; Ujiie I; Iwata H; Izumi K; Nishie W; Shimizu H
Br J Dermatol; 2018 Jun; 178(6):1449-1450. PubMed ID: 29278417
[No Abstract] [Full Text] [Related]
24. Clinical and immunological factors associated with bullous pemphigoid relapse.
Fine JD
JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
[No Abstract] [Full Text] [Related]
25. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
27. Bullous colon lesions in a patient with bullous pemphigoid.
Sachsenberg-Studer EM; Runne U; Wehrmann T; Wolter M; Kriener S; Engels K; Elshorst-Schmidt T; Kaufmann R; Borradori L
Gastrointest Endosc; 2001 Jul; 54(1):104-8. PubMed ID: 11427857
[No Abstract] [Full Text] [Related]
28. Erythema With Nonscarring, Tense Blister Formation Without Circulating Anti-BP180 Antibodies.
Otake-Irie H; Dainichi T; Kabashima K
JAMA Dermatol; 2017 Nov; 153(11):1185-1186. PubMed ID: 28636686
[No Abstract] [Full Text] [Related]
29. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
[No Abstract] [Full Text] [Related]
30. Case of papuloerythroderma of Ofuji-like eruption during the course of bullous pemphigoid.
Hayakawa-Asai R; Nobeyama Y; Maki T; Asahina A; Nakagawa H
J Dermatol; 2018 Mar; 45(3):e63-e64. PubMed ID: 29205461
[No Abstract] [Full Text] [Related]
31. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
[No Abstract] [Full Text] [Related]
32. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
van Beek N; Schulze FS; Zillikens D; Schmidt E
Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
[TBL] [Abstract][Full Text] [Related]
33. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
[TBL] [Abstract][Full Text] [Related]
34. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
35. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
[TBL] [Abstract][Full Text] [Related]
36. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
37. Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid.
Ferreira BR; Vaz AS; Ramos L; Reis JP; Gonçalo M
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329498
[TBL] [Abstract][Full Text] [Related]
38. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
Ujiie H
J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
[TBL] [Abstract][Full Text] [Related]
39. [Case no. 1. Bullous dermatosis].
Ortonne N
Ann Pathol; 2013 Jun; 33(3):178-83. PubMed ID: 23790657
[No Abstract] [Full Text] [Related]
40. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
